Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTeva Provides Update On Generic Seroquel Litigation
Teva Pharmaceutical Industries, 09/28/09
Teva Pharmaceutical Industries Ltd. announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 2008 decision by the District Court to grant AstraZeneca's motion for summary judgment of no inequitable conduct related to U.S. Patent No. 4,879,288. As a result of decision, Teva expects to market its generic version of AstraZeneca's antipsychotic agent Seroquel Tablets no later than March 2012, when the patent is otherwise set to expire.
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09
Sponsor
Article Search
Sponsor